 | Up a level |
2014
Pflug, Natali, Hopfinger, Georg, Cramer, Paula, Schrader, Alexandra, Weit, Nicole, Meister, Rita, Thiel, Miriam, Annolleck, Tanja, Westermann, Anne, Seiler, Till M., Zenz, Thorsten, Duerig, Jan, Bahlo, Jasmin, Kreuzer, Karl-Anton, Stilgenbauer, Stephan, Fink, Anna-Maria, Eichhorst, Barbara, Hallek, Michael and Herling, Marco (2014). Induction Treatment with Alemtuzumab Combined with Polychemotherapy Containing Fludarabine, Cyclophosphamide and Mitoxantrone (FCM) Followed By Alemtuzumab Maintenance in Patients with T-Cell Prolymphocytic Leukaemia (T-PLL): First Analysis of a Prospective Multicenter Phase-II-Trial (T-PLL2) Conducted By the German CLL Study Group (GCLLSG). Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020